GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
Go back to GeneSight® GUIDED Study Published in the Journal of Psychiatric Research| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.46 +0.03 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.43 | 52 Week High | $45.34 | |||
| Open | $4.41 | 52 Week Low | $15.92 | |||
| Day High | $4.50 | P/E | 1.91 | |||
| Day Low | $4.29 | EPS | $2.33 | |||
| Volume | 490,085 | |||||
